Johnson & Johnson (JNJ)
NYSE: JNJ · Real-Time Price · USD
238.64
-1.35 (-0.56%)
At close: Feb 9, 2026, 4:00 PM EST
238.73
+0.09 (0.04%)
Pre-market: Feb 10, 2026, 5:35 AM EST

Johnson & Johnson Revenue

In the year 2025, Johnson & Johnson had annual revenue of $94.19B with 6.05% growth. Johnson & Johnson had revenue of $24.56B in the quarter ending December 31, 2025, with 9.08% growth.

Revenue (ttm)
$94.19B
Revenue Growth
+6.05%
P/S Ratio
6.15
Revenue / Employee
$682,064
Employees
138,100
Market Cap
574.95B

Revenue Chart

Revenue History

Fiscal Year EndRevenueChangeGrowth
Dec 31, 202594.19B5.37B6.05%
Dec 29, 202488.82B3.66B4.30%
Dec 31, 202385.16B5.17B6.46%
Jan 1, 202379.99B1.25B1.59%
Jan 2, 202278.74B-3.84B-4.65%
Jan 3, 202182.58B525.00M0.64%
Dec 29, 201982.06B478.00M0.59%
Dec 30, 201881.58B5.13B6.71%
Dec 31, 201776.45B4.56B6.34%
Jan 1, 201771.89B1.82B2.59%
Jan 3, 201670.07B-4.26B-5.73%
Dec 28, 201474.33B3.02B4.23%
Dec 29, 201371.31B4.09B6.08%
Dec 30, 201267.22B2.19B3.37%
Jan 1, 201265.03B3.44B5.59%
Jan 2, 201161.59B-310.00M-0.50%
Jan 3, 201061.90B-1.85B-2.90%
Dec 28, 200863.75B2.65B4.34%
Dec 30, 200761.10B7.77B14.57%
Dec 31, 200653.32B2.81B5.56%
Jan 1, 200650.51B3.17B6.69%
Jan 2, 200547.35B--

Revenue Definition

Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.

Full Definition

Related Stocks

Company NameRevenue
Eli Lilly and Company65.18B
Merck & Co.65.01B
Pfizer62.58B
AbbVie61.16B
AstraZeneca58.13B
Novartis AG56.67B
Novo Nordisk48.59B
Bristol-Myers Squibb Company48.19B
Revenue Rankings